| Item Type | Name |
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Induction Chemotherapy
|
|
Concept
|
Maintenance Chemotherapy
|
|
Academic Article
|
A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.
|
|
Academic Article
|
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
|
|
Academic Article
|
Non-Hodgkin's lymphoma presenting nine years after ileal-pouch ileoanal anastomosis for ulcerative colitis.
|
|
Academic Article
|
Sulfasalazine vs. steroids in Crohn's disease: David vs. Goliath?
|
|
Academic Article
|
Updating the approach to Crohn's disease.
|
|
Academic Article
|
Immunogenicity of infliximab in Crohn's disease.
|
|
Academic Article
|
The state of the art in the management of inflammatory bowel disease.
|
|
Academic Article
|
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.
|
|
Academic Article
|
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
|
|
Academic Article
|
Devolving therapeutic pyramids.
|
|
Academic Article
|
Medical management of Crohn's disease: treatment algorithms 2009.
|
|
Academic Article
|
Maintenance therapy with certolizumab pegol for Crohn's disease.
|
|
Academic Article
|
Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
|
|
Academic Article
|
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
|
|
Academic Article
|
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
|
|
Academic Article
|
Acute leukemia following inflammatory bowel disease.
|
|
Academic Article
|
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
|
|
Academic Article
|
Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
|
|
Academic Article
|
Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease.
|
|
Academic Article
|
Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin.
|
|
Academic Article
|
Intravenous cyclosporin in ulcerative colitis: a five-year experience.
|
|
Academic Article
|
Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
|
|
Academic Article
|
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis.
|
|
Academic Article
|
Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer.
|
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
|
Academic Article
|
Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
|
|
Academic Article
|
Heading back to the trough (levels of biologics in IBD).
|
|
Academic Article
|
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
|
|
Academic Article
|
Vedolizumab as induction and maintenance therapy for Crohn's disease.
|
|
Academic Article
|
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
|
|
Academic Article
|
Aminosalicylates for induction of remission or response in Crohn's disease.
|
|
Academic Article
|
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
|
|
Academic Article
|
Optimizing pharmacologic management of inflammatory bowel disease.
|
|
Academic Article
|
Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis.
|
|
Academic Article
|
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
|
|
Academic Article
|
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
|
|
Academic Article
|
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
|
|
Academic Article
|
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
|
|
Academic Article
|
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
|
|
Academic Article
|
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
|
|
Academic Article
|
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
|
|
Academic Article
|
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
|
|
Academic Article
|
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
|
|
Academic Article
|
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
|
|
Academic Article
|
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
|
|
Academic Article
|
EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will Combination Pave the Way?
|
|
Academic Article
|
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
|